Table 1 The sibling recurrence risk ratios (λ s ) of individual components of the metabolic syndrome and the syndrome per se in Cohort 1 and Cohort 2.
From: Sibling recurrence risk ratio analysis of the metabolic syndrome and its components over time
Cross-sectional λ s | Lifetime λ s | |||||
|---|---|---|---|---|---|---|
Variable | n | Mean (SD) | Range | λ s,e≥1 | λ s,e≥2 | λ s,e≥3 |
Cohort 1 | ||||||
Hypertension | 21 | 1.22 (0.14) | 1.11–1.72 | 1.03 | 1.04 | 1.07 |
Obesity (high BMI) | 12 | 1.91 (0.48) | 1.37–2.95 | 1.32 | 1.46 | 1.86 |
Hyperglycemia | 14 | 1.39 (0.68) | 0.77–3.57 | 1.14 | 1.28 | 1.47 |
Hypertriglyceridemia | 1A | 1.32 | - | 1.28 | - | - |
Low HDL cholesterol | 3 | 1.34 (0.23) | 1.07–1.52 | 1.21 | 1.50 | 0.34 |
Metabolic syndrome | - | - | 1.21 | - | - | |
Cohort 2B | ||||||
Hypertension | 5 | 1.34 (0.10) | 1.25–1.48 | 1.20 | 1.35 | 1.38 |
Obesity (high BMI) | 5 | 1.60 (0.21) | 1.39–1.89 | 1.40 | 1.54 | 1.56 |
Hyperglycemia | 5 | 1.81 (0.57) | 1.27–2.77 | 1.18 | 1.32 | 2.22 |
Hypertriglyceridemia | 5 | 1.32 (0.19) | 1.09–1.56 | 1.20 | 1.41 | 1.43 |
Low HDL cholesterol | 5 | 1.30 (0.10) | 1.15–1.42 | 1.10 | 1.25 | 1.42 |
Metabolic syndrome | 5 | 1.45 (0.30) | 0.95–1.74 | 1.25 | - | - |